Lack of information and anxiety about talking with doctors remain largest hurdles to PrEP usage
One in four men who have sex with men and use the app Grindr for those purposes reports being on pre-exposure prophylaxis (PrEP), a daily pill regimen that protects against contracting HIV, according to a recent survey.
Grindr, in conjunction with the San Francisco AIDS Foundation, the U.S. Centers for Disease Control and Prevention (CDC) and Gilead Sciences, conducted a survey of
more than 4,700 Grindr users about their use of or attitudes toward PrEP. It should be noted, though, that the results should be taken with a grain of salt, as Gilead Sciences is the company that produces Truvada, currently the only pill approved as a form of PrEP.
According to the Grindr, which released t
he results of its survey on Dec. 1 as part of World AIDS Day, 26 percent of Grindr users reported currently being on PrEP, and another 56 percent say they are interested in taking it in the future. Among all racial cohorts, Latinos were the least likely to be taking PrEP.
The biggest hurdles to PrEP use, as documented by the survey, appeared to be a lack of information or awareness of PrEP — including concerns about side-effects of taking Truvada daily or long-term health effects — and either a lack of information or an unwillingness by health care providers to prescribe or even begin discussions about the possibility of using PrEP. The latter concern dovetails with a recent finding by the
CDC that more than 1 in 3 doctors were unaware of or uncomfortable prescribing PrEP to patients at higher risk of contracting HIV, including gay and bisexual men.
http://www.metroweekly.com/2015/12/1...p-survey-says/